U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:18:03 UTC 2021
Edited
by admin
on Sat Jun 26 18:18:03 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type PARTIAL
Record UNII
B72HH48FLU
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
INFLIXIMAB, LICENSE HOLDER UNSPECIFIED
Preferred Name English
INFLIXIMAB
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
INFLIXIMAB [PURPLE BOOK, CDER]
Common Name English
INFLIXIMAB (GENETICAL RECOMBINATION)
Common Name English
INFLIXIMAB [MART.]
Common Name English
INFLIXIMAB [HSDB]
Common Name English
IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL CA2 HEAVY CHAIN ANTI-HUMAN TUMOR NECROSIS FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CA2 LIGHT CHAIN, DIMER
Common Name English
INFLIXIMAB [VANDF]
Common Name English
INFLIXIMAB [MI]
Common Name English
TA-650
Code English
INFLIXIMAB [WHO-DD]
Common Name English
INFLIXIMAB [EMA EPAR]
Common Name English
INFLIXIMAB [INN]
Common Name English
INFLIXIMAB [USAN]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS REMSIMA (AUTHORIZED: CROHN DISEASE)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
WHO-VATC QL04AB02
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMICADE (AUTHORIZED: SPONDYLITIS, ANKYLOSING)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
NDF-RT N0000175451
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
WHO-ATC L04AB02
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMSIMA (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMSIMA (AUTHORIZED: COLITIS, ULCERATIVE)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMICADE (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMICADE (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
FDA ORPHAN DRUG 168303
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMICADE (AUTHORIZED: CROHN DISEASE)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
LIVERTOX 506
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
FDA ORPHAN DRUG 175803
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS INFLECTRA (AUTHORIZED: CROHN DISEASE)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
FDA ORPHAN DRUG 175903
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS INFLECTRA (AUTHORIZED: SPONDYLITIS, ANKYLOSING)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
FDA ORPHAN DRUG 92495
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
NDF-RT N0000175610
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS INFLECTRA (AUTHORIZED: COLITIS, ULCERATIVE)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
NCI_THESAURUS C20401
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMICADE (AUTHORIZED: COLITIS, ULCERATIVE)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS INFLECTRA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMSIMA (AUTHORIZED: SPODYLITIS, ANKYLOSING)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS INFLECTRA (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
EMA ASSESSMENT REPORTS REMSIMA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
FDA ORPHAN DRUG 160202
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
FDA ORPHAN DRUG 166303
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
Code System Code Type Description
FDA UNII
B72HH48FLU
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
INN
7602
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
JAPANESE REVIEW
REMICADE
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY APPROVED AUGUST 2015
MESH
C108577
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
WIKIPEDIA
INFLIXIMAB
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
RXCUI
2266523
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
ALTERNATIVE
EVMPD
SUB02681MIG
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
DRUG CENTRAL
4974
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
RXCUI
191831
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY RxNorm
MERCK INDEX
M6284
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY Merck Index
LACTMED
Infliximab
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
NCI_THESAURUS
C1789
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
DRUG BANK
DB00065
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
ChEMBL
CHEMBL1201581
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
RXCUI
2103476
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
ALTERNATIVE
IUPHAR
5004
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
CAS
170277-31-3
Created by admin on Sat Jun 26 18:18:04 UTC 2021 , Edited by admin on Sat Jun 26 18:18:04 UTC 2021
PRIMARY
From To
1_22 1_98
2_22 2_98
2_147 2_203
2_223 4_214
2_264 2_324
1_147 1_203
2_370 2_428
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_223 3_214
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
N 3_41
N 4_41
Related Record Type Details
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
INNOVATOR->PARENT
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
TARGET -> AGONIST
TARGET -> INHIBITOR
BINDING
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
BINDING
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE CHEMICAL